DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
PUQUITINIB
Search structure
Synonyms:
Puquitinib dimesylate
Puquitinib dimesylate dihydrate
Puquitinib mesilate
Puquitinib mesylate
Puquitinib mesylate dihydrate
Xc-302
Status:
Phase 1
Entry Type:
Small molecule
Molecule Category:
UNKNOWN
UNII:
WFG29AB872
Pharmacology
Action
Mechanism of Action
Reference
INHIBITOR
Epidermal growth factor receptor erbB1 inhibitor
PubMed
PubMed
DOI
Cross References
Resources
Reference
ChEMBL
CHEMBL3545088
FDA SRS
WFG29AB872
PubChem
15983184
CONTENTS
Structure
Cross References
×
Active Pharmaceutical Ingredients (APIs)
Scaffolds
Exact
Similarity
SubStructure
Threshold (%) >=
70